NCT07517692

Brief Summary

The goal of this pilot clinical trial is to learn whether the patient and provider support program, called FIX-SDM, helps patients and providers engage in shared decision-making for lung cancer screening during primary care visits and increases the number of patients who complete lung cancer screening. The investigators will also assess the acceptability of the support program and the feasibility of the study protocol to prepare for a future large-scale trial. The main questions this trial aims to answer are:

  • Does the patient and provider support increase the number of patients who complete lung cancer screening?
  • Does the patient and provider support help patients and health care providers engage more in shared decision-making and improve the quality of the patient's decision regarding lung cancer screening?
  • Is the study protocol feasible? The investigators will compare the patient and provider support program to usual care to see if the support increases the number of patients who complete lung cancer screening. Primary care provider participants will:
  • Receive the provider support session and educational materials, or follow usual practice
  • Answer a baseline survey and a follow-up survey in 6 months
  • Answer additional survey questions regarding the acceptability of the provider support session if they receive it Patient participants will
  • Receive a smoking history survey, a decision aid, and text messages about lung cancer screening prior to the primary care visit, or receive usual care
  • Complete the baseline survey and two follow-up surveys, one right after the primary care visit and another 3 months after the visit.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
21mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Apr 2026Mar 2028

First Submitted

Initial submission to the registry

March 26, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

1.7 years

First QC Date

March 26, 2026

Last Update Submit

May 11, 2026

Conditions

Keywords

Shared Decision MakingLung Cancer Screeninghealth informatics

Outcome Measures

Primary Outcomes (1)

  • Completion of Lung Cancer Screening (LCS) within 3 months

    The proportion of patients in each arm who completed LCS within 3 months of the index primary care visit

    3 months after the index visit

Secondary Outcomes (17)

  • Completion of LCS within 6 months

    6 months after the index visit

  • LCS order

    3 and 6 months after the index visit

  • LCS appointment

    3 and 6 months after the index visit

  • Patient-reported LCS discussion

    Within 10 days after the index visit

  • Content of LCS discussion

    Within 10 days after the index visit

  • +12 more secondary outcomes

Study Arms (2)

FIX-SDM

EXPERIMENTAL

Primary care providers (PCPs) will receive a support session and educational materials, in addition to the standard electronic alert (e-alert) notification of a patient's possible lung cancer screening eligibility implemented within the healthcare system. Patients will receive a smoking history survey, a decision aid, and text messages about lung cancer screening prior to the primary care visit.

Behavioral: FIX-SDM

Comparator: Usual Care

ACTIVE COMPARATOR

PCPs will receive the standard e-alert notification implemented within the healthcare system (usual practice). Patients will receive the usual care.

Behavioral: Usual Care

Interventions

FIX-SDMBEHAVIORAL

Primary care providers (PCPs) will receive a support session and educational materials, in addition to the standard electronic alert (e-alert) notification of a patient's possible lung cancer screening eligibility implemented within the healthcare system. Patients receive a smoking history survey, a decision aid, and text messages about lung cancer screening prior to the primary care visit.

FIX-SDM
Usual CareBEHAVIORAL

PCPs will receive the standard e-alert notification implemented within the healthcare system (usual practice). Patients will receive the usual care

Comparator: Usual Care

Eligibility Criteria

Age50 Years - 77 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PCPs (physicians or advanced practitioners)
  • Who practice in general internal medicine or family medicine clinics in UMass Memorial Health

You may not qualify if:

  • Participation in the previous study to co-develop the provider intervention (to avoid bias)
  • Patient participants
  • Adults between the ages of 50 and 77
  • Meets criteria for Lung Cancer Screening (LCS) (Current eligibility includes: An individual who currently smokes or quit smoking within 15 years with at least a 20 pack-year smoking history)
  • Has a smartphone with texting capability
  • English-speaking
  • Has a scheduled PCP visit in the next \~3-6 weeks from study enrollment with one of the PCP participants enrolled in the study
  • Prior LCS
  • Chest CT within the last 12 months
  • History of lung cancer
  • Active cancer requiring treatment
  • Supplemental oxygen use
  • Pregnancy
  • Participation in the previous study to co-develop the patient intervention (to avoid bias)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts Chan Medical School

Worcester, Massachusetts, 01605, United States

Location

Study Officials

  • Mayuko Ito Fukunaga, MD, MSc

    UMass Chan Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: A cluster-randomized pilot study randomized at the PCP level (patient allocation clustered with PCP)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

March 26, 2026

First Posted

April 8, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

March 1, 2028

Last Updated

May 14, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

With an executed Data Use Agreement, a limited data set may be shared.

Shared Documents
STUDY PROTOCOL, ICF

Locations